Cytosorbents (CTSO) EPS (Basic) (QoQ) (2010 - 2026)
Cytosorbents (CTSO) EPS (Basic) (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn |
| 10 | Cytosorbents | 21.42 Mn | 17.01 Mn | 7.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.97% |
| Mar 31, 2026 | 7.45% |
| Dec 31, 2025 | -74.86% |
| Sep 30, 2025 | -262.44% |
| Jun 30, 2025 | 227.70% |
| Mar 31, 2025 | 82.48% |
| Dec 31, 2024 | -173.47% |
| Sep 30, 2024 | 35.71% |
| Jun 30, 2024 | 32.52% |
| Mar 31, 2024 | 10.33% |
| Dec 31, 2023 | 36.93% |
| Sep 30, 2023 | -48.21% |
| Jun 30, 2023 | 16.66% |
| Mar 31, 2023 | -853.96% |
| Dec 31, 2022 | 93.72% |
| Sep 30, 2022 | -12.03% |
| Jun 30, 2022 | -21.13% |
| Mar 31, 2022 | 3.95% |
| Dec 31, 2021 | -45.40% |
| Sep 30, 2021 | -36.71% |